Stocks in Focus on December 16: Supriya Lifescience IPO, HP Adhesives IPO, Indiabulls Housing, Power Grid, Wipro and many more

The stock markets ended in red for the fourth consecutive trading session on Wednesday, December 15, 2021. The Sensex at the Bombay Stock Exchange declined 329 points, or 0.57%, to end at 57,788. The Nifty at the National Stock Exchange slipped 104 points, or 0.60%, to 17,221. These stocks can impact the indices when it reopens on Thursday, December 16, 2021. List of such five stocks:

IPO Update: Supriya Lifescience IPO + HP Adhesives IPO + Data Patterns IPO + MedPlus Health IPO

See Zee Business Live TV Streaming Below:

Supriya Lifescience IPO: The initial public offering (IPO) of Supriya Lifescience Limited, a manufacturer and supplier of Active Pharmaceutical Ingredients (API), will open for subscription today, i.e., Thursday, December 16, 2021. The three-day issue will close on Monday, December 20, 2021. The offer price has been fixed at Rs 265-274 per equity share. The company has plans to raise up to Rs 700 crore through this public offer. The issue comprises a fresh issue of up to Rs 200 crore and an offer for sale (OFS) of up to Rs 500 crore. Investors can bid for a minimum of 54 equity shares and in multiples of 54 shares thereof. Retail investors can invest a minimum of Rs 14,796 for one lot, and their maximum investment is Rs 1,92,348 for 13 lots. Besides, the adhesive and sealants company had mopped up Rs 315 crore from anchor investors on Wednesday, a day ahead of the opening of the initial public offer. Nippon Life (17.46%), Dovetail India (12.7%), Cohesion MK (11.1%), Malabar (9.5%), Abakkus Global (9.2%), Kuber India (9.2%), Societe General (3.2%), BNP Paribas (3.2%) among others were the anchor investors to the issue.

HP Adhesives IPO: The initial public offering (IPO) of HP Adhesives Limited, an adhesive and sealants company, was subscribed 3.48 times by the day on the first day of bidding. The Non-Institutional Investors (NIIs) and Retail Individual Investors (RIIs) portions were subscribed 0.38 times and 18.57 times, respectively. The three-day issue will close on Friday, December 17, 2021. The company has fixed a price of Rs 262-274 per equity share. The company has plans to raise up to Rs 125.9 crore from the primary market. The maiden issue comprises a fresh issue of 41,40,000 equity shares worth Rs 113.44 crore and an offer for sale (OFS) of 4,57,200 equity shares worth Rs 12.5 crore. A retail investor can place a bid for a minimum of 50 equity shares and in multiples thereof.

Data Patterns IPO: The initial public offering (IPO) of Data Patterns (India) Limited, a vertically integrated defence and aerospace electronics solutions provider, was subscribed 7.68 times on Wednesday, the second day for bidding. The Qualified Institutional Buyers (QIBs) portion was subscribed 0.92 per cent while the Non-Institutional Investors (NIIs) and Retail Individual Investors (RIIs) portions were subscribed 5.2 times and 12.42 times, respectively. The three-day issue will close on Thursday, December 16, 2021. The company has fixed a price range of Rs 555-585 per equity share for an issue worth Rs 588 crore. The maiden issue comprises a fresh issue component up to Rs 240 crore and an offer for sale (OFS) worth Rs 348 crore. A retail investor can bid for a minimum of 25 equity shares and in multiples thereafter. At the upper end of the price band, one lot is worth Rs 14,625.

MedPlus Health IPO: The initial public offering (IPO) of MedPlus Health Services Limited, a pharmacy retailer, closed with 52.59 times subscription on Wednesday, December 15, 2021. The Qualified Institutional Buyers (QIBs) was subscribed 111.9 times while the Non-Institutional Investors (NII) and Retail Individual Investors (RIIs) portions were subscribed 85.33 times and 5.24 times, respectively. The portion reserved for employees was subscribed 3.05 times. The company had fixed a price range of Rs 780-796 per equity share as it has plans to raise up to Rs 1,398 crore from the primary market. The pubic issue of the pharmacy retailer consists of the issuance of fresh equity shares worth Rs 600 crore while and an offer for sale (OFS) of equity shares aggregating up to Rs 798 crore by the promoter and existing shareholders. A retail investor can bid for a minimum of 18 equity shares and in multiples thereafter.

Sapphire Foods: The one month lock-in period for anchor investors ends today.

Indiabulls Housing: Sameer Gehlaut, the founder of mortgage financier Indiabulls Housing Finance, will sell an 11.9% stake in the company via a block deal. He will offload his stake in the range of Rs 262.35-Rs 267.60 per share and the deal is valued at over Rs 1,400 crore. US private equity giant Blackstone and UAE sovereign wealth fund Abu Dhabi Investment Authority (ADIA) will purchase the stakes.

Power Grid: Power Grid Corporation of India Ltd's (PGCIL) board on Wednesday approved the payment of Interim Dividend of Rs7 per equity share of Rs. 10/- each (including Special Dividend of Rs 3 per equity share) i.e. @70% of the paid-up equity share capital for the Financial Year 2021-22. The Interim Dividend shall be paid to the Members on January 11, 2022.

Sun Pharmaceutical: Sun Pharma including its subsidiaries and/or associate companies on Wednesday announced that one of its wholly-owned subsidiaries has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic Amphotericin B Liposome for Injection, 50 mg/vial Single-Dose Vial. The generic product approval is based on AmBisome® Liposome for Injection, 50 mg/vial as a reference product. As per October 2021 IQVIA Health data, AmBisome® Liposome for Injection, 50mg/vial had annualized sales of approximately US$ 136 million in the USA.

Ashok Leyland: The automotive manufacturer's electric vehicle arm Switch Mobility will be setting up a new manufacturing and technology centre in Spain. It will invest about €100 million (Rs 860 crore) in the region in the next 10 years.

Wipro: Wipro has introduced regulatory literature monitoring for pharmaceutical organizations by entering a managed services engagement with Springer Nature. As per the agreement, Wipro will take over the ADIS Pharmacovigilance business from Springer Nature. Besides, the IT company has entered into a partnership with Italy-based UMPI, a manufacturer of intelligent products and systems, who will use the Wipro Sewage Monitor to empower water companies in Europe to improve accuracy and efficiency as they monitor their systems. In addition, the company has announced that it has signed an agreement to acquire LeanSwift Solutions, a Florida, US-headquartered system integrator of Infor Products at a consideration of USD 21 million.

MMTC/STC: Central Board of Indirect Taxes & Customs (CBIT&C) has consulted RBI and Security Printing and Minting Corporation of India Limited (SPMCIL) and also signed a tripartite Memorandum of Understanding (MOU) with them. SPMCIL shall now be responsible for the collection, transportation, conversion into standard gold bars and delivery to RBI. The sale of customs confiscated gold by MMTC for the FY 2019-20 and 2020-21 was Rs. 23.49 crores and 105.14 crores respectively, contributing less than 1% of the entire bullion business of MMTC. Earlier, it was routed through all public sector banks (approved by RBI to import and sell gold), MMTC Ltd. and STC Ltd. The decision was taken after the disinvestment of Neelachal Ispat Nigam Ltd. (NINL)- a JV company of MMTC. Request for proposal has been issued by SBI Caps to shortlisted bidders, the closing date of which is December 23, 2021.

Reliance Industries/Sterling & Wilson Solar: The Competition Commission of India (CCI) on Wednesday approved the acquisition of a shareholding in Sterling and Wilson Renewable Energy Limited (SWREL) by Reliance Industries' wholly-owned subsidiary Reliance New Energy Solar Limited (RNESL).

Ansal Housing: HDFC has sold 21.5 lakh shares of the company at Rs 13.94 per share.